12:00 AM
 | 
Dec 11, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Leuprogel leuprolide: Phase III

In a Phase III study of its once monthly (7.5 mg) Leuprogel, ATRX said the product suppressed serum testosterone with no incidences of testosterone breakthrough. Levels of...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >